Aurora Spine Corporation (ASG.V)
CAD 0.34
(-4.23%)
CAD 0.34
(-4.23%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 8.21 Million USD | 5.14% |
| 2022 | 7.8 Million USD | 61.57% |
| 2021 | 4.83 Million USD | 39.35% |
| 2020 | 3.46 Million USD | -2.22% |
| 2019 | 3.54 Million USD | -22.77% |
| 2018 | 4.59 Million USD | 79.47% |
| 2017 | 2.55 Million USD | -24.37% |
| 2016 | 3.38 Million USD | 25.74% |
| 2015 | 2.69 Million USD | 85.37% |
| 2014 | 1.45 Million USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.48 Million USD | 8.25% |
| 2024 Q2 | 2.54 Million USD | 2.54% |
| 2024 Q3 | 2.88 Million USD | 13.16% |
| 2023 Q2 | 2.03 Million USD | 32.92% |
| 2023 Q4 | 2.29 Million USD | -2.63% |
| 2023 Q3 | 2.35 Million USD | 16.04% |
| 2023 FY | 8.21 Million USD | 5.14% |
| 2023 Q1 | 1.52 Million USD | -16.3% |
| 2022 Q2 | 2.14 Million USD | 12.56% |
| 2022 Q1 | 1.9 Million USD | 39.52% |
| 2022 Q4 | 1.82 Million USD | -5.99% |
| 2022 FY | 7.8 Million USD | 61.57% |
| 2022 Q3 | 1.94 Million USD | -9.27% |
| 2021 FY | 4.83 Million USD | 39.35% |
| 2021 Q1 | 1.11 Million USD | 22.93% |
| 2021 Q3 | 1.35 Million USD | 35.09% |
| 2021 Q4 | 1.36 Million USD | 0.49% |
| 2021 Q2 | 1 Million USD | -9.58% |
| 2020 Q2 | 646.39 Thousand USD | -17.26% |
| 2020 Q4 | 903.24 Thousand USD | -20.62% |
| 2020 FY | 3.46 Million USD | -2.22% |
| 2020 Q3 | 1.13 Million USD | 76.03% |
| 2020 Q1 | 781.21 Thousand USD | 850.02% |
| 2019 Q2 | 1.28 Million USD | 10.66% |
| 2019 FY | 3.54 Million USD | -22.77% |
| 2019 Q4 | 82.23 Thousand USD | -91.87% |
| 2019 Q3 | 1.01 Million USD | -21.51% |
| 2019 Q1 | 1.16 Million USD | -5.69% |
| 2018 Q4 | 1.23 Million USD | -8.99% |
| 2018 FY | 4.59 Million USD | 79.47% |
| 2018 Q1 | 876.84 Thousand USD | 163.59% |
| 2018 Q2 | 1.12 Million USD | 28.23% |
| 2018 Q3 | 1.35 Million USD | 20.69% |
| 2017 Q1 | 793.67 Thousand USD | -1.87% |
| 2017 FY | 2.55 Million USD | -24.37% |
| 2017 Q2 | 726.96 Thousand USD | -8.41% |
| 2017 Q4 | 332.65 Thousand USD | -52.88% |
| 2017 Q3 | 705.93 Thousand USD | -2.89% |
| 2016 Q1 | 805.03 Thousand USD | 5.35% |
| 2016 Q3 | 798.72 Thousand USD | -17.76% |
| 2016 Q4 | 808.83 Thousand USD | 1.27% |
| 2016 Q2 | 971.25 Thousand USD | 20.65% |
| 2016 FY | 3.38 Million USD | 25.74% |
| 2015 Q4 | 764.15 Thousand USD | 2.83% |
| 2015 Q3 | 743.14 Thousand USD | 46.23% |
| 2015 FY | 2.69 Million USD | 85.37% |
| 2015 Q2 | 508.2 Thousand USD | -24.78% |
| 2015 Q1 | 675.62 Thousand USD | -11.81% |
| 2014 Q1 | 177.55 Thousand USD | 0.0% |
| 2014 Q2 | 256 Thousand USD | 44.18% |
| 2014 Q3 | 252.1 Thousand USD | -1.53% |
| 2014 Q4 | 766.07 Thousand USD | 203.88% |
| 2014 FY | 1.45 Million USD | 0.0% |
| 2013 Q3 | 36.94 Thousand USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -498.94 Thousand CAD | 1745.724% |
| Therma Bright Inc. | 23.89 Thousand CAD | -34258.308% |
| Theralase Technologies Inc. | 562.13 Thousand CAD | -1360.736% |
| VentriPoint Diagnostics Ltd. | 42.43 Thousand CAD | -19250.738% |